SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178879-23-000009
Filing Date
2023-05-10
Accepted
2023-05-10 16:04:21
Documents
63
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fold-20230331.htm   iXBRL 10-Q 1017765
2 EX-31.1 fold-03312023xex311.htm EX-31.1 11157
3 EX-31.2 fold-03312023xex312.htm EX-31.2 11230
4 EX-32.1 fold-03312023xex321.htm EX-32.1 8654
  Complete submission text file 0001178879-23-000009.txt   5364297

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20230331.xsd EX-101.SCH 29876
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20230331_cal.xml EX-101.CAL 64679
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20230331_def.xml EX-101.DEF 126084
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fold-20230331_lab.xml EX-101.LAB 477760
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20230331_pre.xml EX-101.PRE 298977
57 EXTRACTED XBRL INSTANCE DOCUMENT fold-20230331_htm.xml XML 835268
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33497 | Film No.: 23906258
SIC: 2834 Pharmaceutical Preparations